Accumulating data suggest that the relative increase in DKK-1 expression in prostate cancer may have direct effects on tumor proliferation and the cell cycle [124], while the inhibition of DKK-1 reduces the tumor burden in prostate cancer [125]. The gene discussed is DKK1; the disease is prostate carcinoma.